36
Participants
Start Date
October 1, 2014
Primary Completion Date
July 30, 2019
Study Completion Date
July 31, 2019
tocilizumab
given at a dose of 8mg/kg by IV infusion every 4 weeks at 6 time points (Visits 1, 2, 3, 4, 5 and 6).
placebo
given by IV infusion every 4 weeks at 6 time points (Visits 1, 2, 3, 4, 5 and 6).
North Shore Long Island Jewish Center, Great Neck
University of Pittsburgh, Pittsburgh
Vanderbilt University, Nashville
Medical College of Wisconsin, Milwaukee
Mayo Clinic, Rochester
University of Kansas Medical Center, Kansas City
Cedars Sinai Medical Center, Los Angeles
Collaborators (1)
Genentech, Inc.
INDUSTRY
Chester Oddis
OTHER